NIOCORP DEVELOPMENTS LTD/ CA6544846091 /
03/05/2024 21:54:41 | Chg. - | Volume | Bid22:25:20 | Demandez à22:25:20 | Haut | Bas |
---|---|---|---|---|---|---|
3.43CAD | - | 38,930 Chiffrre d'affaires: 125,419 |
3.23Bid taille: 5,000 | 3.60Ask la taille: 100 | 3.60 | 2.84 |
GlobeNewswire
09:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
09:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
09:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
09:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
08:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
07:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page